HCN1
protein-codinghyperpolarization activated cyclic nucleotide gated potassium channel 1, the group of Cyclic nucleotide gated channels
Gene summary
The membrane protein encoded by this gene is a hyperpolarization-activated cation channel that contributes to the native pacemaker currents in heart and neurons. The encoded protein can homodimerize or heterodimerize with other pore-forming subunits to form a potassium channel. This channel may act as a receptor for sour tastes. [provided by RefSeq, Oct 2011]
- BCNG1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~441.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032777
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0018214
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0018614
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0018214
Submitter: ClinGen
*HCN1* was first reported in relation to patients with autosomal dominant epilepsy in 2014 (Nava et al., PMID: 24747641). Since then, there have been assertions for both a relationship between *HCN1* and autosomal dominant developmental and epileptic encephalopathy (DEE), and between *HCN1* and autosomal dominant generalized epilepsy with febrile seizures plus (GEFS+). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we have not found evidence of differences in disease mechanism between probands diagnosed with either GEFS+ or DEE; further, there are currently no discernable genotype-phenotype correlations, and no known differences in disease mechanism between these two entities (PMID: 34310985). The Epilepsy GCEP has therefore lumped these cases into one curation for autosomal dominant GEFS+ (MONDO:0018214), including probands with presentations of infantile epileptic encephalopathy on the severe end of the spectrum, as well as individuals with milder presentations. Twenty missense variants reported in 26 probands in four publications are included in this curation (PMIDs: 27864847, 30351409, 24747641, 35359652). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Both purported loss of function and gain of function variants in *HCN1* have been identified in patients with autosomal dominant GEFS+ (PMID: 34310985). This gene-disease relationship is also supported by mouse models (PMIDs: 33822003, 35972069). In summary, there is definitive evidence supporting the relationship between *HCN1* and autosomal dominant GEFS+. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.This classification was approved by the ClinGen Epilepsy GCEP on the meeting date January 3, 2023 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0014377
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014377
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0032777
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014377
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: As with other forms of epilepsy, optimal seizure control is advantageous, and genetic diagnosis may aid with medication selection
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HCN1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021072.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 288 | 5 | 300 | ||
| missense | 19 | 28 | 504 | 87 | 1 | 639 |
| nonsense | 17 | 1 | 18 | |||
| start loss | 3 | 3 | ||||
| frameshift | 2 | 25 | 27 | |||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 19 | 30 | 566 | 376 | 6 | 997 |
Highest pathogenic variant AF is 0.000044621775
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_066550.2 | 8 | MANE Select | |
| Ensembl | ENSP00000307342.4 | 8 | MANE Select | |
| Ensembl | ENSP00000489134.1 | 2 | Standard | |
| Ensembl | ENSP00000501107.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuronal System
- HCN channels
- Potassium Channels
Biological Process
- regulation of ion transmembrane transport
- sodium ion transmembrane transport
- regulation of membrane potential
- apical protein localization
- retinal cone cell development
Molecular Function
- intracellular cAMP-activated cation channel activity
- voltage-gated sodium channel activity
- voltage-gated potassium channel activity
- potassium channel activity
- protein binding
Cellular Component
- plasma membrane
- integral component of plasma membrane
- axon
- dendrite
- HCN channel complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000303230
- Coding exons
- 8
- Length
- 436905
- Individuals with no LoFs
- 125743
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 5
- Defined
- 125748
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.66 | 261 | 489 | 0.534 | 0.0000278 | 5792 |
| Missense (PolyPhen) | 80 | 216.2 | 0.37002 | 2516 | ||
| Synonymous | -2.32 | 242 | 200 | 1.21 | 0.0000130 | 1801 |
| Loss of Function | 5.15 | 2 | 34.8 | 0.0575 | 0.00000196 | 377 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000044 | 0.000044 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Hyperpolarization-activated ion channel exhibiting weak selectivity for potassium over sodium ions (PubMed:28086084). Contributes to the native pacemaker currents in heart (If) and in neurons (Ih). May mediate responses to sour stimuli. {ECO:0000269|PubMed:15351778, ECO:0000269|PubMed:28086084}.;
- Disease
- DISEASE: Epileptic encephalopathy, early infantile, 24 (EIEE24) [MIM:615871]: A disease characterized by early-onset seizures, intellectual disability of varying degrees, and behavioral disturbances or autistic features in most individuals. {ECO:0000269|PubMed:24747641, ECO:0000269|PubMed:27864847}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- LoFtool
- 0.111
- RVIS EVS
- -0.76
- RVIS percentile EVS
- 13.33
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.801
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |